Viewing Study NCT01354457


Ignite Creation Date: 2025-12-24 @ 6:35 PM
Ignite Modification Date: 2025-12-29 @ 2:18 PM
Study NCT ID: NCT01354457
Status: UNKNOWN
Last Update Posted: 2014-06-25
First Post: 2009-07-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+
Sponsor: Nantes University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module